Specifically, the NOD1 ligand-induced insulin resistance do not involve significant elevation of serum cytokines, which is in contrast to the response of low-dose LPS, the major contributor of metabolic endotoxemia (Schertzer et al., 2011). This evidence concerns the gene NOD1 and Insulin resistance.